Company Quick10K Filing
Weis Markets
10-Q 2021-03-27 Filed 2021-05-06
10-K 2020-12-26 Filed 2021-03-11
10-Q 2020-09-26 Filed 2020-11-05
10-Q 2020-06-27 Filed 2020-08-05
10-Q 2020-03-28 Filed 2020-05-07
10-K 2019-12-28 Filed 2020-03-12
10-Q 2019-09-28 Filed 2019-11-04
10-Q 2019-06-29 Filed 2019-08-06
10-Q 2019-03-30 Filed 2019-05-09
10-K 2018-12-29 Filed 2019-03-14
10-Q 2018-09-29 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-30 Filed 2018-03-15
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-07-01 Filed 2017-08-10
10-Q 2017-04-01 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-03-16
10-Q 2016-09-24 Filed 2016-11-03
10-Q 2016-06-25 Filed 2016-07-28
10-Q 2016-03-26 Filed 2016-05-05
10-K 2015-12-26 Filed 2016-03-18
10-Q 2015-09-26 Filed 2016-02-16
10-Q 2015-06-27 Filed 2015-08-04
10-Q 2015-03-28 Filed 2015-05-01
10-K 2014-12-27 Filed 2015-03-13
10-Q 2014-09-27 Filed 2014-11-06
10-Q 2014-06-28 Filed 2014-08-07
10-Q 2014-03-29 Filed 2014-05-08
10-K 2013-12-28 Filed 2014-03-14
10-Q 2013-09-28 Filed 2013-11-07
10-Q 2013-06-29 Filed 2013-08-08
10-Q 2013-03-30 Filed 2013-05-09
10-K 2012-12-29 Filed 2013-03-14
10-Q 2012-09-29 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-03-15
10-Q 2011-09-24 Filed 2011-11-03
10-Q 2011-06-25 Filed 2011-08-04
10-Q 2011-03-26 Filed 2011-05-05
10-K 2010-12-25 Filed 2011-03-10
10-Q 2010-09-25 Filed 2010-11-04
10-Q 2010-06-26 Filed 2010-08-05
10-Q 2010-03-27 Filed 2010-05-06
10-K 2009-12-26 Filed 2010-03-11
8-K 2020-11-02
8-K 2020-08-03
8-K 2020-05-04
8-K 2020-04-30
8-K 2020-03-09
8-K 2019-11-18
8-K 2019-11-04
8-K 2019-08-27
8-K 2019-08-02
8-K 2019-05-03
8-K 2019-04-25
8-K 2019-03-11
8-K 2018-11-02
8-K 2018-08-03
8-K 2018-05-07
8-K 2018-04-26
8-K 2018-03-13

Weis Markets Financials

WMK Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-252011-09-242011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-28
Cash71783737473421243628182722252317241618303413151218202150353838325277
Accounts Receivable52475252585254665554576268647166696788837073967776728348535657485453
Inventory231231229226224229277275267268280267273281281281266263
PP&E5445535755765956181,5936556686831,6857077087131,7537197187281,8337467547942,0308708718752,0918838868812,140883877881
Assets1,0071,0181,0291,0441,0681,0741,0901,1191,1241,1341,1481,1581,1461,1591,1911,1871,1881,2031,2361,2331,2291,3001,4311,3991,3931,4061,4421,4191,4121,4241,4321,6081,6021,637
Accounts Payable119118132127132128126129121130134132123129145137133142160139136164199171179187216200192192191177168183
Long-Term Debt40647152523518000
Liabilities255257283287295291295310301308314316300307333324317340364349337406505469452469449418401407409578560589
Stockholders' Equity7527617467587737837968088238268348428478528588638718638728848928949279319419379931,0011,0121,0181,0231,0291,0421,048
Income Statement ($MM)2011-06-252011-09-242011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-28
Revenue677679738662677668694683676661686687718684714712718712734738730743925852986854884876871869893877888876
Cost of Revenue494495546478489487504492476479505500526498521517519518536531528538667622721631650641619637666647651643
Gross Profit183183192183188181191191200183181187192186193195199194199207202205258230265223234235252232227230237233
R&D
SG&A151157163153152155156160158165156164168166172176174175173176178189231210233217212212214215214211215
Tax1291011161013121771088787961296109132-41674565
Net Income2117192026172220271216151614141316131720151141122046416311413142014
Cash Flow ($MM)2011-06-252011-09-242011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-28
Cash Operating41492341312836423134342236313133363836384015553660513328344561
Cash Investing-26-54-15-24-36-33-25-22-31-29-17-19-24-26-29-18-17-24-91-54-15-22-26-34-23-23-16-31-17-28
Cash Financing-8-35-8-8-8-8-8-8-8-8-8-8-8-8-8-8-8-8-83216-2-27-8-25-25-26-8-8-8-8